HER2-positive Breast Cancer Registry (PRO-HER2)

Priyanka Sharma

Status: Enrolling

Conditions: HER2 + Breast Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT06603597

160944

Details and patient eligibility

About

The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Stage I-IV HER2-positive breast cancer

Exclusion criteria

• None

Trial design

1,000 participants in 1 patient group

HER2-positive breast cancer

Description:

Patients with stage I-IV HER2-positive breast cancer